Apricus Biosciences jumps on German phase approval for Vitaros

|By:, SA News Editor

Apricus Biosciences (APRI) gets national phase approval (the company's fifth) in Germany for Vitaros.

The company says the five remaining European phase approvals should be obtainable in Q4 and Q1 2014.

Vitaros' application for marketing approval is approved under the Decentralized Procedure. The Netherlands is the RMS.

APRI has multiple partners for the ED treatment including Takeda (TKPHF.PK), Sandoz, and Abbott (ABT). (PR)

APRI +10% premarket.